Uptake of community-based, self-collected HPV testing vs. visual inspection with acetic acid for cervical cancer screening in Kampala, Uganda: Preliminary results of a randomised controlled trial

Tropical Medicine and International Health

Volumn 20, Issue 10, 2015, Pages 1355-1367

  Moses, Erin ^a   Pedersen, Heather N ^b   Mitchell, Sheona M ^b   Sekikubo, Musa ^c   Mwesigwa, David ^d   Singer, Joel ^b   Biryabarema, Christine ^c   Byamugisha, Josaphat K ^c   Money, Deborah M ^a,b   Ogilvie, Gina S ^a,b  

^a WOMEN S HEALTH RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c MAKERERE UNIVERSITY   (Uganda)

^d Kisenyi Health Unit   (Uganda)

Author keywords

Cervical cancer; Community based; Human papillomavirus; Screening; Self collection

Indexed keywords

ACETIC ACID; DYES, REAGENTS, INDICATORS, MARKERS AND BUFFERS;

ACETIC ACID; CANCER; FEASIBILITY STUDY; HEALTH RISK; LABORATORY METHOD; PUBLIC HEALTH; TESTING METHOD; VIRUS;

ADULT; AGED; ARTICLE; CANCER SCREENING; CERVICO VAGINAL SWAB; CHLAMYDIA TRACHOMATIS; COLPOSCOPY; CONTROLLED STUDY; CRYOTHERAPY; DIAGNOSTIC TEST ACCURACY STUDY; FEMALE; FOLLOW UP; HEALTH CARE QUALITY; HEALTH CENTER; HUMAN; MAJOR CLINICAL STUDY; NEISSERIA GONORRHOEAE; PATIENT REFERRAL; PELVIC EXAMINATION; PILOT STUDY; RANDOMIZED CONTROLLED TRIAL; SELF EVALUATION; TREATMENT REFUSAL; UGANDA; UTERINE CERVIX CANCER; UTERINE CERVIX CYTOLOGY; WART VIRUS; EARLY DIAGNOSIS; FEASIBILITY STUDY; ISOLATION AND PURIFICATION; LABORATORY DIAGNOSIS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PROCEDURES; SELF CARE; UTERINE CERVICAL NEOPLASMS; UTILIZATION; VIROLOGY;

UGANDA;

HUMAN PAPILLOMAVIRUS;

ACETIC ACID; ADULT; EARLY DETECTION OF CANCER; FEASIBILITY STUDIES; FEMALE; HUMANS; INDICATORS AND REAGENTS; MASS SCREENING; MIDDLE AGED; PAPILLOMAVIRIDAE; PAPILLOMAVIRUS INFECTIONS; PILOT PROJECTS; SELF CARE; SPECIMEN HANDLING; UGANDA; UTERINE CERVICAL NEOPLASMS;

EID: 84941191916     PISSN: 13602276     EISSN: 13653156     Source Type: Journal    
DOI: 10.1111/tmi.12549     Document Type: Article

References (22)

1. Walboomers JM, Jacobs MV, Manos MM et al. Human papillomavirus is a necessary cause of invasive cervical cancer worldwide. J Pathol 1999: 189: 12-19.
2. Farmer P, Frenk J, Knaul FM et al. Expansion of cancer care and control in countries of low and middle income: a call to action. Lancet 2010: 376: 1186-1193.
3. Ferlay J, Soerjomataram I & Ervik M, et al. GLOBOCAN 2012, Cancer Incidence and Mortality Worldwide. IARC CancerBase. 2012;11. (Available from: http://globocan.iarc.fr) [13 December 2013].
4. Anorlu RI. Cervical cancer: the sub-Saharan African perspective. Reprod Health Matters 2008: 16: 41-49.
5. World Health Organization. Comprehensive Cervical Cancer Control A Guide to Essential Practice - 2nd ed. 2014. (Available from: http://apps.who.int/iris/bitstream/10665/144785/1/9789241548953_eng.pdf?ua=1) [19 December 2014].
6. World Health Organization. WHO Guidelines for Screening and Treatment of Precancerous Lesions for Cervical Cancer Prevention. 2013:40. (Available from: http://apps.who.int/iris/bitstream/10665/94830/1/9789241548694_eng.pdf?ua=1) [14 November 2014].
7. Blumenthal PD, Gaffikin L, Deganus S et al. Cervical cancer prevention: safety, acceptability, and feasibility of a single-visit approach in Accra, Ghana. Am J Obstet Gynecol 2007: 196: 407-408.
8. World Health Organization. Prevention of Cervical Cancer Through Screening Using Visual Inspection with Acetic Acid (VIA) and Treatment with Cryotherapy: A Demonstration Project in Six African Countries (Malawi, Madagascar, Nigeria, Uganda, the United Republic of Tanzania, and Zambia). 2012. (Available from: http://apps.who.int/iris/bitstream/10665/75250/1/9789241503860_eng.pdf?ua=1) [01 December 2014].
9. Wright TC Jr, Kuhn L. Alternative approaches to cervical cancer screening for developing countries. Best Pract Res Clin Obstet Gynaecol 2012: 26: 197-208.
10. Ogilvie GS, Mitchell S, Sekikubo M et al. Results of a community-based cervical cancer screening pilot project using human papillomavirus self-sampling in Kampala, Uganda. Int J Gynaecol Obstet 2013: 122: 118-123.
11. Snijders PJ, Verhoef VM, Arbyn M et al. High-risk HPV testing on self-sampled versus clinician-collected specimens: a review on the clinical accuracy and impact on population attendance in cervical cancer screening. Int J Cancer 2013: 132: 2223-2236.
12. Steben M, Jeronimo J, Wittet S et al. Upgrading public health programs for human papillomavirus prevention and control is possible in low- and middle-income countries. Vaccine 2012: 30(Suppl 5): F183-F191.
13. Lazcano-Ponce E, Lorincz AT, Cruz-Valdez A et al. Self-collection of vaginal specimens for human papillomavirus testing in cervical cancer prevention (MARCH): a community-based randomised controlled trial. Lancet 2011: 378: 1868-1873.
14. Ogilvie G, Krajden M, Maginley J et al. Feasibility of self-collection of specimens for human papillomavirus testing in hard-to-reach women. CMAJ 2007: 177: 480-483.
15. Mitchell S, Ogilvie G, Steinberg M, Sekikubo M, Biryabarema C, Money D. Assessing women's willingness to collect their own cervical samples for HPV testing as part of the ASPIRE cervical cancer screening project in Uganda. Int J Gynaecol Obstet 2011: 114: 111-115.
16. Teng FF, Mitchell SM, Sekikubo M et al. Understanding the role of embarrassment in gynaecological screening: a qualitative study from the ASPIRE cervical cancer screening project in Uganda. BMJ Open 2014: 4: e004783.
17. Mitchell S, Sekikubo M, Biryabarema C et al. Factors associated with high-risk HPV positivity in a low-resource setting in sub-Saharan Africa. Am J Obstet Gynecol 2014: 1: e1-e7.
18. Money D, Moses E, Pedersen H, Sekikubo M, Mitchell S, Mwesigwa D et al., editors. Cervical cancer screening in women living with HIV using self-collection based human papillomavirus testing in Uganda. 5th International Workshop on HIV & Women; 2015; Seattle.
19. Ecoli sro. PCR Diagnostics.Edu. 2015. (Available from: http://www.pcrdiagnostics.eu/en/Products/HPV-Infections.alej) [19 February 2015].
20. Hain Life Science. GenoQuick Technology. (Available from: http://www.hain-lifescience.de/en/technologies/genoquick.html) [19 February 2015].
21. BioScience S. CinnaGen SmarTaq DNA Polymerase. 2013. (Available from: http://sinaclon.com/product-31-Real-Time-PCR-Master-Mixes-HotTaq-EvaGreen%C2%AE-qPCR-Mix) [19 February 2015].
22. Hosmer DW, Lemeshow S, Sturdivant RX. Wiley Series in Probability and Statistics: Applied Logistic Regression (3rd edn). Wiley: New York, NY, 2013.